Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Parkinson's Disease

  Free Subscription


Articles published in Neurosci Lett

Retrieve available abstracts of 167 articles:
HTML format
Text format



Single Articles


    July 2018
  1. LI D, Song X, Huang H, Huang H, et al
    Association of Parkinson's disease-related pain with plasma interleukin-1, interleukin-6, interleukin-10, and tumour necrosis factor-alpha.
    Neurosci Lett. 2018 Jul 28. pii: S0304-3940(18)30500.
    PubMed     Text format     Abstract available


  2. GE F, Ding J, Liu Y, Lin H, et al
    Cerebrospinal fluid NFL in the differential diagnosis of parkinsonian disorders: a meta-analysis.
    Neurosci Lett. 2018 Jul 20. pii: S0304-3940(18)30503.
    PubMed     Text format     Abstract available


  3. ROSAS-HERNANDEZ H, Chigurupati S, Raymick J, Robinson B, et al
    Identification of altered microRNAs in serum of a mouse model of Parkinson's disease.
    Neurosci Lett. 2018;687:1-9.
    PubMed     Text format     Abstract available


  4. SI QQ, Yuan YS, Zhi Y, Tong Q, et al
    Plasma transferrin level correlates with the tremor-dominant phenotype of Parkinson's disease.
    Neurosci Lett. 2018;684:42-46.
    PubMed     Text format     Abstract available


    June 2018
  5. MARTIN-RODRIGUEZ JF, Mir P
    Short-afferent inhibition and cognitive impairment in Parkinson's disease: A Quantitative Review and Challenges.
    Neurosci Lett. 2018 Jun 27. pii: S0304-3940(18)30451.
    PubMed     Text format     Abstract available


  6. SHEN YT, Li JY, Yuan YS, Wang XX, et al
    Disrupted amplitude of low-frequency fluctuations and causal connectivity in Parkinson's disease with apathy.
    Neurosci Lett. 2018;683:75-81.
    PubMed     Text format     Abstract available


  7. LUCA A, Nicoletti A, Mostile G, Sciacca G, et al
    Temperament Traits And Executive Functions In Parkinson's Disease.
    Neurosci Lett. 2018 Jun 22. pii: S0304-3940(18)30443.
    PubMed     Text format     Abstract available


  8. LUOMA J, Pekkonen E, Airaksinen K, Helle L, et al
    Spontaneous sensorimotor cortical activity is suppressed by deep brain stimulation in patients with advanced Parkinson's disease.
    Neurosci Lett. 2018 Jun 22. pii: S0304-3940(18)30444.
    PubMed     Text format     Abstract available


  9. KWIATEK-MAJKUSIAK J, Geremek M, Koziorowski D, Tomasiuk R, et al
    Higher serum levels of pro-hepcidin in patients with Parkinson's disease treated with deep brain stimulation.
    Neurosci Lett. 2018 Jun 18. pii: S0304-3940(18)30434.
    PubMed     Text format     Abstract available


  10. DU G, Zhuang P, Zhang Y, Li J, et al
    Neuronal firing rate and oscillatory patterns in the basal ganglia nuclei differ from those of the ventrolateral thalamus in patients with Parkinson disease.
    Neurosci Lett. 2018;683:1-6.
    PubMed     Text format     Abstract available


  11. PING Z, Xiaomu W, Xufang X, Wenfeng C, et al
    GAPDH rs1136666 SNP indicates a high risk of Parkinson's disease.
    Neurosci Lett. 2018 Jun 7. pii: S0304-3940(18)30416.
    PubMed     Text format     Abstract available


  12. NAGARAJAN VB, Marathe PA
    Effect of montelukast in experimental model of Parkinson's disease.
    Neurosci Lett. 2018 Jun 6. pii: S0304-3940(18)30403.
    PubMed     Text format     Abstract available


    May 2018
  13. SHU L, Zhang Y, Sun Q, Pan H, et al
    SNCA REP1 and Parkinson's disease.
    Neurosci Lett. 2018 May 30. pii: S0304-3940(18)30394.
    PubMed     Text format     Abstract available


  14. POWELL DW, Blackmore SE, Puppa M, Lester D, et al
    Deep brain stimulation enhances movement complexity during gait in individuals with Parkinson's disease.
    Neurosci Lett. 2018 May 8. pii: S0304-3940(18)30337.
    PubMed     Text format     Abstract available


  15. BEGUM M ET, Sen D
    DOR agonist (SNC-80) exhibits anti-parkinsonian effect via downregulating UPR/oxidative stress signals and inflammatory response in vivo.
    Neurosci Lett. 2018;678:29-36.
    PubMed     Text format     Abstract available


    April 2018
  16. FANG L, Tang BS, Fan K, Wan CM, et al
    Alzheimer's disease susceptibility genes modify the risk of Parkinson disease and Parkinson's disease-associated cognitive impairment.
    Neurosci Lett. 2018 Apr 23. pii: S0304-3940(18)30305.
    PubMed     Text format     Abstract available


  17. WANG P, Guo Y, Song C, Liu Y, et al
    PINK1 p.K520RfsX3 Mutation Identified in a Chinese Family with Early-onset Parkinson's disease.
    Neurosci Lett. 2018 Apr 12. pii: S0304-3940(18)30283.
    PubMed     Text format     Abstract available


  18. SHEEHAN P, Yue Z
    Deregulation of autophagy and vesicle trafficking in Parkinson's disease.
    Neurosci Lett. 2018 Apr 5. pii: S0304-3940(18)30268.
    PubMed     Text format     Abstract available


  19. CHU CT
    Multiple pathways for mitophagy: A neurodegenerative conundrum for Parkinson's disease.
    Neurosci Lett. 2018 Apr 4. pii: S0304-3940(18)30259.
    PubMed     Text format     Abstract available


    March 2018
  20. CROOKS SA, Bech S, Halling J, Christiansen DH, et al
    Carnitine levels and mutations in the SLC22A5 gene in Faroes patients with Parkinson's disease.
    Neurosci Lett. 2018;675:116-119.
    PubMed     Text format     Abstract available


  21. LI W, Jiang Y, Wang Y, Yang S, et al
    MiR-181b regulates autophagy in a model of Parkinson's disease by targeting the PTEN/Akt/mTOR signaling pathway.
    Neurosci Lett. 2018;675:83-88.
    PubMed     Text format     Abstract available


  22. SADHUKHAN D, Das G, Biswas A, Ghosh S, et al
    Evaluation of FGF 20 variants for susceptibility to Parkinson's disease in Eastern Indians.
    Neurosci Lett. 2018 Mar 28. pii: S0304-3940(18)30236.
    PubMed     Text format     Abstract available


  23. GENG L, Zhang T, Liu W, Chen Y, et al
    miR-494-3p modulates the progression of in vitro and in vivo Parkinson's disease models by targeting SIRT3.
    Neurosci Lett. 2018;675:23-30.
    PubMed     Text format     Abstract available


  24. HOU Y, Luo C, Yang J, Ou R, et al
    Altered intrinsic brain functional connectivity in drug-naive Parkinson's disease patients with LRRK2 mutations.
    Neurosci Lett. 2018 Mar 19. pii: S0304-3940(18)30215.
    PubMed     Text format     Abstract available


  25. MAPLE-GRODEM J, Chung J, Lunde KA, Tzoulis C, et al
    Alzheimer disease associated variants in SORL1 accelerate dementia development in Parkinson disease.
    Neurosci Lett. 2018;674:123-126.
    PubMed     Text format     Abstract available


  26. WATANABE T, Saito K, Ishida K, Tanabe S, et al
    Effect of auditory stimulus on executive function and execution time during cognitively demanding stepping task in patients with Parkinson's disease.
    Neurosci Lett. 2018 Mar 17. pii: S0304-3940(18)30209.
    PubMed     Text format     Abstract available


  27. POCHMANN D, Peccin PK, da Silva IRV, Dorneles GP, et al
    Cytokine modulation in response to acute and chronic aquatic therapy intervention in Parkinson disease individuals: A pilot study.
    Neurosci Lett. 2018 Mar 11. pii: S0304-3940(18)30190.
    PubMed     Text format     Abstract available


  28. JIN H, Chen J, Li K, Zhang JR, et al
    A novel p.L216I mutation in the glucocerebrosidase gene is associated with Parkinson's disease in Han Chinese patients.
    Neurosci Lett. 2018 Mar 9. pii: S0304-3940(18)30186.
    PubMed     Text format     Abstract available


    February 2018
  29. GUO T, Guan X, Zeng Q, Xuan M, et al
    Correlations between CSF proteins and spontaneous neuronal activity in Parkinson's disease.
    Neurosci Lett. 2018;673:61-66.
    PubMed     Text format     Abstract available


  30. DUTTA P, Dargahi L, O'Connell KE, Bolia A, et al
    A novel modelling mechanism of PAEL receptor and GABARAPL2 interaction involved in Parkinson's disease.
    Neurosci Lett. 2018;673:12-18.
    PubMed     Text format     Abstract available


  31. DI NATALE C, Monaco A, Pedone C, Tessitore A, et al
    THE LEVEL OF 24-HYDROXYCHOLESTERYL ESTERS DECREASES IN PLASMA OF PATIENTS WITH PARKINSON'S DISEASE.
    Neurosci Lett. 2018 Feb 24. pii: S0304-3940(18)30123.
    PubMed     Text format     Abstract available


  32. JIANG X, Wang X, Tuo M, Ma J, et al
    RAGE and its emerging role in the pathogenesis of Parkinson's disease.
    Neurosci Lett. 2018 Feb 22. pii: S0304-3940(18)30131.
    PubMed     Text format     Abstract available


  33. ZHENG X, Chen X, Guo M, Ali S, et al
    Changes in salsolinol production and salsolinol synthase activity in Parkinson's disease model.
    Neurosci Lett. 2018 Feb 15. pii: S0304-3940(18)30100.
    PubMed     Text format     Abstract available


  34. SILVEIRA CRA, Roy EA, Almeida QJ
    Acute effects of aerobic exercise on cognitive function in individuals with Parkinson's disease.
    Neurosci Lett. 2018 Feb 3. pii: S0304-3940(18)30068.
    PubMed     Text format     Abstract available


    January 2018
  35. MAO W, Zhao C, Ding H, Liang K, et al
    Pyrosequencing analysis of methylation levels of clock genes in leukocytes from Parkinson's disease patients.
    Neurosci Lett. 2018;668:115-119.
    PubMed     Text format     Abstract available


  36. WANG X, Li J, Wang M, Yuan Y, et al
    Alterations of the amplitude of low-frequency fluctuations in anxiety in Parkinson's disease.
    Neurosci Lett. 2018;668:19-23.
    PubMed     Text format     Abstract available


  37. MOON HC, Won SY, Kim EG, Kim HK, et al
    Effect of optogenetic modulation on entopeduncular input affects thalamic discharge and behavior in an AAV2-alpha-synuclein-induced hemiparkinson rat model.
    Neurosci Lett. 2018;662:129-135.
    PubMed     Text format     Abstract available


  38. ZHENG Q, Huang C, Guo J, Tan J, et al
    Hsp70 participates in PINK1-mediated mitophagy by regulating the stability of PINK1.
    Neurosci Lett. 2018;662:264-270.
    PubMed     Text format     Abstract available


    December 2017
  39. SEKAR S, Taghibiglou C
    Elevated nuclear phosphatase and tensin homolog (PTEN) and altered insulin signaling in substantia nigral region of patients with Parkinson's disease.
    Neurosci Lett. 2017;666:139-143.
    PubMed     Text format     Abstract available


  40. WANG L, Nie K, Zhao X, Feng S, et al
    Characteristics of gray matter morphological change in Parkinson's disease patients with semantic abstract reasoning deficits.
    Neurosci Lett. 2017 Dec 21. pii: S0304-3940(17)31020.
    PubMed     Text format     Abstract available


  41. CHENG Y, Mao CY, Liu YT, Li F, et al
    Analysis of variant rs3794087 in SLC1A2 and Parkinson's disease in a Chinese Han population: a case-control study and meta-analysis.
    Neurosci Lett. 2017 Dec 21. pii: S0304-3940(17)31018.
    PubMed     Text format     Abstract available


  42. HARRISON IF, Smith AD, Dexter DT
    Pathological histone acetylation in Parkinson's disease: Neuroprotection and inhibition of microglial activation through SIRT 2 inhibition.
    Neurosci Lett. 2017;666:48-57.
    PubMed     Text format     Abstract available


  43. AN C, Pu X, Xiao W, Zhang H, et al
    Expression of the DJ-1 protein in the serum of Chinese patients with Parkinson's disease.
    Neurosci Lett. 2017;665:236-239.
    PubMed     Text format     Abstract available


  44. BREZA M, Koutsis G, Karadima G, Potagas C, et al
    The different faces of the p. A53T alpha-synuclein mutation: a screening of Greek patients with parkinsonism and/or dementia.
    Neurosci Lett. 2017 Dec 9. pii: S0304-3940(17)30988.
    PubMed     Text format     Abstract available


    November 2017
  45. LI XR, Ren YD, Cao B, Huang XL, et al
    Analysis of white matter characteristics with tract-based spatial statistics according to diffusion tensor imaging in early Parkinson's disease.
    Neurosci Lett. 2017 Nov 30. pii: S0304-3940(17)30973.
    PubMed     Text format     Abstract available


  46. DU K, Liu MY, Pan YZ, Zhong X, et al
    Association of circulating manganese levels with Parkinson's disease: A meta-analysis.
    Neurosci Lett. 2017;665:92-98.
    PubMed     Text format     Abstract available


  47. CAI M, Liu Z, Li W, Wang Y, et al
    Association between rs823128 polymorphism and the risk of Parkinson's disease: A meta-analysis.
    Neurosci Lett. 2017 Nov 27. pii: S0304-3940(17)30966.
    PubMed     Text format     Abstract available


  48. PAPAGIANNAKIS N, Koros C, Stamelou M, Simitsi AM, et al
    Alpha-synuclein dimerization in erythrocytes of patients with genetic and non-genetic forms of Parkinson's Disease.
    Neurosci Lett. 2017 Nov 9. pii: S0304-3940(17)30910.
    PubMed     Text format     Abstract available


  49. YUAN XQ, Cao B, Wu Y, Chen YP, et al
    Association analysis of SNP rs11868035 in SREBF1 with sporadic Parkinson's disease, sporadic amyotrophic lateral sclerosis and multiple system atrophy in a Chinese population.
    Neurosci Lett. 2017 Nov 8. pii: S0304-3940(17)30913.
    PubMed     Text format     Abstract available


    October 2017
  50. LIU L, Zhang L, Guo L, Yu Q, et al
    MTHFR C677T and A1298C polymorphisms may contribute to the risk of Parkinson's disease: A meta-analysis of 19 studies.
    Neurosci Lett. 2017;662:339-345.
    PubMed     Text format     Abstract available


  51. WU Q, Gao Y, Liu AS, Xie LZ, et al
    Large-scale cortical volume correlation networks reveal disrupted small world patterns in Parkinson's disease.
    Neurosci Lett. 2017 Oct 20. pii: S0304-3940(17)30858.
    PubMed     Text format     Abstract available


  52. MATSUURA K, Kajikawa H, Tabei KI, Satoh M, et al
    The effectiveness of istradefylline for the treatment of gait deficits and sleepiness in patients with Parkinson's disease.
    Neurosci Lett. 2017 Oct 12. pii: S0304-3940(17)30836.
    PubMed     Text format     Abstract available


    September 2017
  53. KONG P, Lei P, Zhang S, Li D, et al
    Integrated microarray analysis provided a new insight of the pathogenesis of Parkinson's disease.
    Neurosci Lett. 2017 Sep 28. pii: S0304-3940(17)30793.
    PubMed     Text format     Abstract available


  54. GMITTEROVA K, Gawinecka J, Heinemann U, Valkovic P, et al
    DNA versus RNA oxidation in Parkinson's disease: which is more important?
    Neurosci Lett. 2017 Sep 26. pii: S0304-3940(17)30790.
    PubMed     Text format     Abstract available


  55. ABBAOUI A, Chatoui H, Hiba OE, Gamrani H, et al
    Neuroprotective effect of curcumin-I in copper-induced dopaminergic neurotoxicity in rats: A possible link with Parkinson's disease.
    Neurosci Lett. 2017 Sep 14. pii: S0304-3940(17)30774.
    PubMed     Text format     Abstract available


  56. XI J, Yang X, Zhao Q, Zheng J, et al
    Absence of association of the Ala58Val (rs17571) CTSD gene variant with Parkinson's disease or amyotrophic lateral sclerosis in a Han Chinese population.
    Neurosci Lett. 2017 Sep 13. pii: S0304-3940(17)30771.
    PubMed     Text format     Abstract available


  57. FLACH A, Jaegers L, Krieger M, Bixler E, et al
    Endurance Exercise Improves Function in Individuals with Parkinson's Disease: A Meta-analysis.
    Neurosci Lett. 2017 Sep 1. pii: S0304-3940(17)30733.
    PubMed     Text format     Abstract available


    August 2017
  58. CAO H, Shi J, Cao B, Kang B, et al
    Evaluation of the Braak staging of brain pathology with 1H-MRS in patients with Parkinson's disease.
    Neurosci Lett. 2017 Aug 24. pii: S0304-3940(17)30697.
    PubMed     Text format     Abstract available


  59. LINDENAU JD, Altmann V, Schumacher-Schuh AF, Rieder CR, et al
    Tumor necrosis factor alpha polymorphisms are associated with Parkinson's disease age at onset.
    Neurosci Lett. 2017 Aug 24. pii: S0304-3940(17)30696.
    PubMed     Text format     Abstract available


  60. FANG J, Hou B, Liu H, Zhang X, et al
    Association between SNCA rs2736990 polymorphism and Parkinson's disease: a meta-analysis.
    Neurosci Lett. 2017;658:102-107.
    PubMed     Text format     Abstract available


  61. LUDTMANN MHR, Abramov AY
    Mitochondrial calcium imbalance in Parkinson's disease.
    Neurosci Lett. 2017 Aug 21. pii: S0304-3940(17)30691.
    PubMed     Text format     Abstract available


  62. BERGE-SEIDL V, Pihlstrom L, Maple-Grodem J, Forsgren L, et al
    The GBA variant E326K is associated with Parkinson's disease and explains a genome-wide association signal.
    Neurosci Lett. 2017 Aug 19. pii: S0304-3940(17)30687.
    PubMed     Text format     Abstract available


  63. GAO Y, Nie K, Huang B, Mei M, et al
    Changes of brain structure in Parkinson's disease patients with mild cognitive impairment analyzed via VBM technology.
    Neurosci Lett. 2017 Aug 17. pii: S0304-3940(17)30675.
    PubMed     Text format     Abstract available


  64. LV W, Guan Q, Hu X, Chen J, et al
    Vestibulo-ocular reflex abnormality in Parkinson's disease detected by video head impulse test.
    Neurosci Lett. 2017 Aug 11. pii: S0304-3940(17)30668.
    PubMed     Text format     Abstract available


  65. HE T, Wang J, Wang X, Deng W, et al
    Association between PARK16 and Parkinson's disease: a meta-analysis.
    Neurosci Lett. 2017 Aug 11. pii: S0304-3940(17)30669.
    PubMed     Text format     Abstract available


  66. XIAO H, Li M, Cai J, Li N, et al
    Selective cholinergic depletion of pedunculopontine tegmental nucleus aggravates freezing of gait in parkinsonian rats.
    Neurosci Lett. 2017 Aug 10. pii: S0304-3940(17)30663.
    PubMed     Text format     Abstract available


  67. FANG J, Chen H, Cao Z, Jiang Y, et al
    Impaired Brain Network Architecture in Newly Diagnosed Parkinson's Disease Based on Graph Theoretical Analysis.
    Neurosci Lett. 2017 Aug 5. pii: S0304-3940(17)30638.
    PubMed     Text format     Abstract available


    July 2017
  68. RINGMAN JM, Casado M, Van Berlo V, Pa J, et al
    A novel PSEN1 (S230N) mutation causing early-onset Alzheimer's Disease associated with prosopagnosia, hoarding, and Parkinsonism.
    Neurosci Lett. 2017 Jul 29. pii: S0304-3940(17)30618.
    PubMed     Text format     Abstract available


  69. WEILAN Y, Weiguo Y, Baisheng H, Lixiang W, et al
    Neuroprotective Effects of Lentivirus-mediated Cystathionine-beta-synthase Overexpression against 6-OHDA-induced Parkinson's Disease Rats.
    Neurosci Lett. 2017 Jul 29. pii: S0304-3940(17)30581.
    PubMed     Text format     Abstract available


  70. LI X, Xue L, Sun J, Sun Y, et al
    Single nucleotide polymorphisms in the toll-like receptor 2 (TLR2) gene are associated with sporadic Parkinson's disease in the North-eastern Han Chinese population.
    Neurosci Lett. 2017;656:72-76.
    PubMed     Text format     Abstract available


  71. REED-JONES RJ, Powell DW
    The effects of gaze stabilization on gait parameters in individuals with Parkinson's disease.
    Neurosci Lett. 2017 Jul 11. pii: S0304-3940(17)30573.
    PubMed     Text format     Abstract available


  72. YAO Z, Shao Y, Han X
    Freezing of gait is associated with cognitive impairment in patients with Parkinson disease.
    Neurosci Lett. 2017 Jul 8. pii: S0304-3940(17)30555.
    PubMed     Text format     Abstract available


    June 2017
  73. DIBILIO V, Nicoletti A, Mostile G, Portaro G, et al
    Computer-Assisted Cognitive Rehabilitation on Freezing of Gait in Parkinson's Disease: A Pilot Study.
    Neurosci Lett. 2017 Jun 9. pii: S0304-3940(17)30486.
    PubMed     Text format     Abstract available


  74. HE D, Hu P, Deng X, Song Z, et al
    Genetic analysis of the RIC3 gene in Han Chinese patients with Parkinson's disease.
    Neurosci Lett. 2017 Jun 9. pii: S0304-3940(17)30487.
    PubMed     Text format     Abstract available


  75. WANG X, Zhang J, Yuan Y, Li T, et al
    Cerebral metabolic change in Parkinson's disease patients with anxiety: A FDG-PET study.
    Neurosci Lett. 2017;653:202-207.
    PubMed     Text format     Abstract available


  76. SHIN JH, Shin SA, Lee JY, Nam H, et al
    Precuneus degeneration and isolated apathy in patients with Parkinson's disease.
    Neurosci Lett. 2017;653:250-257.
    PubMed     Text format     Abstract available


    May 2017
  77. HAO Y, Shabanpoor A, Metz GA
    Stress and corticosterone alter synaptic plasticity in a rat model of Parkinson's disease.
    Neurosci Lett. 2017;651:79-87.
    PubMed     Text format     Abstract available


    April 2017
  78. PENG B, Wang S, Zhou Z, Liu Y, et al
    A multilevel-ROI-features-based machine learning method for detection of morphometric biomarkers in Parkinson's disease.
    Neurosci Lett. 2017 Apr 20. pii: S0304-3940(17)30335.
    PubMed     Text format     Abstract available


  79. LIU H, Liu H, Li T, Cui J, et al
    NR4A2 genetic variation and Parkinson's disease: evidence from a systematic review and meta-analysis.
    Neurosci Lett. 2017 Apr 3. pii: S0304-3940(17)30090.
    PubMed     Text format     Abstract available


  80. YANG X, Zheng J, An R, Tian S, et al
    Polymorphism in MIR4697 but not VPS13C, GCH1, or SIPA1L2 is associated with risk of Parkinson's disease in a Han Chinese population.
    Neurosci Lett. 2017 Apr 2. pii: S0304-3940(17)30287.
    PubMed     Text format     Abstract available


    March 2017
  81. CHEN S, Liu Y, Niu Y, Xu Y, et al
    Increased abundance of myeloid-derived suppressor cells and Th17 cells in peripheral blood of newly-diagnosed Parkinson's disease patients.
    Neurosci Lett. 2017 Mar 27. pii: S0304-3940(17)30275.
    PubMed     Text format     Abstract available


  82. KUMARI N, Agrawal S, Luthra PM
    Pharmacological assessments of potent A2A receptor antagonist IDPU (1-(7-imino-3-propyl-2,3-dihydrothiazolo[4,5-d]pyrimidin-6(7H)-yl)urea) in rodent model of haloperidol induced Parkinson like symptoms.
    Neurosci Lett. 2017;647:53-60.
    PubMed     Text format     Abstract available


  83. DEMETER G, Valalik I, Pajkossy P, Szollosi A, et al
    The effect of deep brain stimulation of the subthalamic nucleus on executive functions: Impaired verbal fluency and intact updating, planning and conflict resolution in Parkinson's disease.
    Neurosci Lett. 2017 Mar 18. pii: S0304-3940(17)30247.
    PubMed     Text format     Abstract available


  84. WANG L, Huang J, Pang S, Qin X, et al
    Genetic analysis of the ATG16L1 gene promoter in sporadic Parkinson's disease.
    Neurosci Lett. 2017;646:30-35.
    PubMed     Text format     Abstract available


    February 2017
  85. TANG Y, Meng L, Wan CM, Liu ZH, et al
    Identifying the presence of Parkinson's disease using low-frequency fluctuations in BOLD signals.
    Neurosci Lett. 2017 Feb 26. pii: S0304-3940(17)30172.
    PubMed     Text format     Abstract available


  86. CAO XY, Lu JM, Zhao ZQ, Li MC, et al
    MicroRNA biomarkers of Parkinson's disease in serum exosome-like microvesicles.
    Neurosci Lett. 2017 Feb 18. pii: S0304-3940(17)30161.
    PubMed     Text format     Abstract available


  87. TANAKA K, Miyake Y, Fukushima W, Kiyohara C, et al
    Vitamin D receptor gene polymorphisms, smoking, and risk of sporadic Parkinson's disease in Japan.
    Neurosci Lett. 2017;643:97-102.
    PubMed     Text format     Abstract available


  88. FATHALLA AM, Soliman AM, Moustafa AA
    Selective A2A receptors blockade reduces degeneration of substantia nigra dopamine neurons in a rotenone-induced rat model of Parkinson's disease: A histological study.
    Neurosci Lett. 2017;643:89-96.
    PubMed     Text format     Abstract available


  89. MIKI Y, Tanji K, Mori F, Kakita A, et al
    PLA2G6 accumulates in Lewy bodies in PARK14 and idiopathic Parkinson's disease.
    Neurosci Lett. 2017 Feb 14. pii: S0304-3940(17)30133.
    PubMed     Text format     Abstract available


  90. LI Y, Huang J, Pang S, Wang H, et al
    Novel and functional ATG12 gene variants in sporadic Parkinson's disease.
    Neurosci Lett. 2017 Feb 13. pii: S0304-3940(17)30134.
    PubMed     Text format     Abstract available


  91. TIAN S, Yang X, Zhao Q, Zheng J, et al
    Association between a heme oxygenase-2 genetic variant and risk of Parkinson's disease in Han Chinese.
    Neurosci Lett. 2017 Feb 5. pii: S0304-3940(17)30114.
    PubMed     Text format     Abstract available


    January 2017
  92. KANG SY, Lee SB, Kim HJ, Kim HT, et al
    Autophagic modulation by rosuvastatin prevents rotenone-induced neurotoxicity in an in vitro model of Parkinson's disease.
    Neurosci Lett. 2017 Jan 27. pii: S0304-3940(17)30091.
    PubMed     Text format     Abstract available


  93. CORBILLE AG, Preterre C, Rolli-Derkinderen M, Coron E, et al
    Biochemical analysis of alpha-synuclein extracted from control and Parkinson's disease colonic biopsies.
    Neurosci Lett. 2017 Jan 23. pii: S0304-3940(17)30070.
    PubMed     Text format     Abstract available


  94. ZHANG Y, Wu JY, Weng LH, Li XX, et al
    Valproic acid protects against MPP(+)-mediated neurotoxicity in SH-SY5Y Cells through autophagy.
    Neurosci Lett. 2017;638:60-68.
    PubMed     Text format     Abstract available


  95. BRIFFA M, Ghio S, Neuner J, Gauci AJ, et al
    Extracts from two ubiquitous Mediterranean plants ameliorate cellular and animal models of neurodegenerative proteinopathies.
    Neurosci Lett. 2017;638:12-20.
    PubMed     Text format     Abstract available


    December 2016
  96. PEZZI JC, Bem CM, Rocha TJ, Schumacher-Schuh AF, et al
    Association between DNA methyltransferase gene polymorphism and Parkinson's disease.
    Neurosci Lett. 2016 Dec 29. pii: S0304-3940(16)31006.
    PubMed     Text format     Abstract available


  97. RIAL D, Morato X, Real JI, Goncalves FQ, et al
    Parkinson's disease-associated GPR37 receptor regulates cocaine-mediated synaptic depression in corticostriatal synapses.
    Neurosci Lett. 2016;638:162-166.
    PubMed     Text format     Abstract available


  98. XIANG Y, Gong T, Wu J, Li J, et al
    Subtypes evaluation of motor dysfunction in Parkinson's disease using neuromelanin-sensitive magnetic resonance imaging.
    Neurosci Lett. 2016;638:145-150.
    PubMed     Text format     Abstract available


    November 2016
  99. XIE Y, Feng H, Peng S, Xiao J, et al
    Association of plasma homocysteine, vitamin B12 and folate levels with cognitive function in Parkinson's disease: A meta-analysis.
    Neurosci Lett. 2016 Nov 10. pii: S0304-3940(16)30846.
    PubMed     Text format     Abstract available


  100. LATTARI E, Costa SS, Campos C, de Oliveira AJ, et al
    Can transcranial direct current stimulation on the dorsolateral prefrontal cortex improves balance and functional mobility in Parkinson's disease?
    Neurosci Lett. 2016 Nov 9. pii: S0304-3940(16)30861.
    PubMed     Text format     Abstract available


  101. CAO CY, Zeng K, Li DY, Zhan SK, et al
    Modulations on cortical oscillations by Subthalamic deep brain stimulation in patients with Parkinson disease: a MEG study.
    Neurosci Lett. 2016 Nov 3. pii: S0304-3940(16)30848.
    PubMed     Text format     Abstract available


    October 2016
  102. PCHELINA S, Emelyanov A, Baydakova G, Andoskin P, et al
    Oligomeric alpha-synuclein and glucocerebrosidase activity levels in GBA-associated Parkinson's disease.
    Neurosci Lett. 2016 Oct 22. pii: S0304-3940(16)30792.
    PubMed     Text format     Abstract available


  103. ABREU GM, Valenca DC, Campos M Junior, da Silva CP, et al
    Autosomal dominant Parkinson's disease: Incidence of mutations in LRRK2, SNCA, VPS35 and GBA genes in Brazil.
    Neurosci Lett. 2016;635:67-70.
    PubMed     Text format     Abstract available


  104. DENG X, Tang CY, Zhang J, Zhu L, et al
    The cortical thickness correlates of clinical manifestations in the mid-stage sporadic Parkinson's disease.
    Neurosci Lett. 2016;633:279-289.
    PubMed     Text format     Abstract available


  105. HOU Y, Luo C, Yang J, Song W, et al
    A resting-state fMRI study on early-stage drug-naive Parkinson's disease patients with drooling.
    Neurosci Lett. 2016 Oct 4. pii: S0304-3940(16)30749.
    PubMed     Text format     Abstract available


    September 2016
  106. ZENG W, Liu F, Wang Q, Wang Y, et al
    Parkinson's disease classification using gait analysis via deterministic learning.
    Neurosci Lett. 2016 Sep 27. pii: S0304-3940(16)30726.
    PubMed     Text format     Abstract available


  107. SHI C, Li F, Yang J, Zhang S, et al
    DNAJC6 mutations are not common causes of early onset Parkinson's disease in Chinese Han population.
    Neurosci Lett. 2016 Sep 26. pii: S0304-3940(16)30727.
    PubMed     Text format     Abstract available


  108. DENG X, Li FJ, Tang CY, Zhang J, et al
    The cortical surface correlates of clinical manifestations in the mid-stage sporadic Parkinson's disease.
    Neurosci Lett. 2016 Sep 17. pii: S0304-3940(16)30707.
    PubMed     Text format     Abstract available


  109. MATSUURA K, Maeda M, Tabei KI, Umino M, et al
    A longitudinal study of neuromelanin-sensitive magnetic resonance imaging in Parkinson's disease.
    Neurosci Lett. 2016 Sep 9. pii: S0304-3940(16)30684.
    PubMed     Text format     Abstract available


    August 2016
  110. CEN L, Xiao Y, Wei L, Mo M, et al
    Association of DYRK1A polymorphisms with sporadic Parkinson's disease in Chinese Han population.
    Neurosci Lett. 2016 Aug 18. pii: S0304-3940(16)30601.
    PubMed     Text format     Abstract available


    July 2016
  111. MCKEOWN B KIN MD, Peters RM, Pasman EP, McKeown MJ, et al
    Plantar cutaneous function in Parkinson's disease patients ON and OFF L-dopa.
    Neurosci Lett. 2016 Jul 14. pii: S0304-3940(16)30515.
    PubMed     Text format     Abstract available


  112. CROSIERS D, Verstraeten A, Wauters E, Engelborghs S, et al
    Mutations in glucocerebrosidase are a major genetic risk factor for Parkinson's disease and increase susceptibility to dementia in a Flanders-Belgian cohort.
    Neurosci Lett. 2016 Jul 7. pii: S0304-3940(16)30494.
    PubMed     Text format     Abstract available


    June 2016
  113. NAIR VD, Ge Y
    Alterations of miRNAs reveal a dysregulated molecular regulatory network in Parkinson's disease striatum.
    Neurosci Lett. 2016 Jun 28. pii: S0304-3940(16)30470.
    PubMed     Text format     Abstract available


  114. WU H, Lu X, Xie F, Cen Z, et al
    Genetic analysis of the CHCHD2 gene in a cohort of Chinese patients with Parkinson disease.
    Neurosci Lett. 2016 Jun 25. pii: S0304-3940(16)30463.
    PubMed     Text format     Abstract available


  115. LI XY, Teng JJ, Liu Y, Wu YB, et al
    Association of AKT1 Gene Polymorphisms with Sporadic Parkinson's disease in Chinese Han Population.
    Neurosci Lett. 2016 Jun 25. pii: S0304-3940(16)30461.
    PubMed     Text format     Abstract available


  116. LU Q, Song Z, Deng X, Xiong W, et al
    SLC6A3 rs28363170 and rs3836790 variants in Han Chinese patients with sporadic Parkinson's disease.
    Neurosci Lett. 2016 Jun 25. pii: S0304-3940(16)30462.
    PubMed     Text format     Abstract available


  117. KANG SY, Park S, Oh E, Park J, et al
    Vitamin D receptor polymorphisms and Parkinson's disease in a Korean population: Revisited.
    Neurosci Lett. 2016 Jun 21. pii: S0304-3940(16)30450.
    PubMed     Text format     Abstract available


  118. SHIN MS, Jeong HY, An DI, Lee HY, et al
    Corrigendum to "Treadmill exercise facilitates synaptic plasticity on dopaminergic neurons and fibers in the mouse model with Parkinson's disease" [Neurosci. Lett. (2016) 28-33].
    Neurosci Lett. 2016 Jun 20. pii: S0304-3940(16)30328.
    PubMed     Text format    


  119. BHATTACHARJEE N, Khairujjaman Mazumder M, Paul R, Choudhury A, et al
    L-DOPA treatment in MPTP-mouse model of Parkinson's disease potentiates homocysteine accumulation in substantia nigra.
    Neurosci Lett. 2016 Jun 6. pii: S0304-3940(16)30410.
    PubMed     Text format     Abstract available


  120. TARD C, Devanne H, Defebvre L, Delval A, et al
    Single session intermittent theta-burst stimulation on the left premotor cortex does not alleviate freezing of gait in Parkinson's disease.
    Neurosci Lett. 2016 Jun 3. pii: S0304-3940(16)30391.
    PubMed     Text format     Abstract available


    May 2016
  121. GEBREMEDHIN KG, Rademacher DJ
    Histone H3 Acetylation in the Postmortem Parkinson's Disease Primary Motor Cortex.
    Neurosci Lett. 2016 May 27. pii: S0304-3940(16)30390.
    PubMed     Text format     Abstract available


  122. GULLY JC, Sergeyev VG, Bhootada Y, Mendez-Gomez H, et al
    Up-regulation of activating transcription factor 4 induces severe loss of dopamine nigral neurons in a rat model of Parkinson's disease.
    Neurosci Lett. 2016 May 24. pii: S0304-3940(16)30359.
    PubMed     Text format     Abstract available


  123. SWANK C, Mehta J, Criminger C
    Transcranial Direct Current Stimulation Lessens Dual Task Cost in People with Parkinson's Disease.
    Neurosci Lett. 2016 May 12. pii: S0304-3940(16)30309.
    PubMed     Text format     Abstract available


  124. CHEN H, Huang X, Yuan L, Xia H, et al
    A homozygous parkin p.G284R mutation in a Chinese family with autosomal recessive juvenile parkinsonism.
    Neurosci Lett. 2016 May 10. pii: S0304-3940(16)30310.
    PubMed     Text format     Abstract available


    April 2016
  125. WANG X, Zhang X, Xue L, Xie A, et al
    The association between the LRRK2 R1628P variant and the risk of Parkinson's disease in Asian: a meta-analysis.
    Neurosci Lett. 2016 Apr 28. pii: S0304-3940(16)30278.
    PubMed     Text format     Abstract available


  126. SOLIMAN AM, Fathalla AM, Moustafa AA
    Dose-Dependent Neuroprotective Effect of Caffeineon a Rotenone-Induced Rat Model of Parkinsonism: A histological study.
    Neurosci Lett. 2016 Apr 27. pii: S0304-3940(16)30279.
    PubMed     Text format     Abstract available


  127. XU Y, Chen Y, Ou R, Wei QQ, et al
    No association of GPNMB rs156429 polymorphism with Parkinson's disease, amyotrophic lateral sclerosis and multiple system atrophy in Chinese population.
    Neurosci Lett. 2016;622:113-117.
    PubMed     Text format     Abstract available


  128. FAN K, Tang BS, Wang YQ, Kang JF, et al
    The GBA, DYRK1A and MS4A6A polymorphisms influence the age at onset of Chinese Parkinson patients.
    Neurosci Lett. 2016;621:133-136.
    PubMed     Text format     Abstract available


  129. SHIN MS, Jeong HY, An DI, Lee HY, et al
    Treadmill exercise facilitates synaptic plasticity on dopaminergic neurons and fibers in the mouse model with Parkinson's disease.
    Neurosci Lett. 2016 Apr 11. pii: S0304-3940(16)30220.
    PubMed     Text format     Abstract available


  130. KELM-NELSON CA, Stevenson SA, Ciucci MR
    Atp13a2 expression in the periaqueductal gray is decreased in the Pink1 -/- rat model of Parkinson disease.
    Neurosci Lett. 2016 Apr 4. pii: S0304-3940(16)30208.
    PubMed     Text format     Abstract available


    March 2016
  131. TANIK N, Serin HI, Celikbilek A, Inan LE, et al
    Associations of olfactory bulb and depth of olfactory sulcus with basal ganglia and hippocampus in patients with Parkinson's disease.
    Neurosci Lett. 2016;620:111-114.
    PubMed     Text format     Abstract available


  132. VAN DER MERWE C, Carr J, Glanzmann B, Bardien S, et al
    Exonic rearrangements in the known Parkinson's disease-causing genes are a rare cause of the disease in South African patients.
    Neurosci Lett. 2016 Mar 18. pii: S0304-3940(16)30166.
    PubMed     Text format     Abstract available


  133. MITRA S, Ghosh N, Sinha P, Chakrabarti N, et al
    Alteration of nuclear factor-kappaB pathway promote neuroinflammation depending on the functions of estrogen receptors in substantia nigra after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment.
    Neurosci Lett. 2016;616:86-92.
    PubMed     Text format     Abstract available


    February 2016
  134. EMAMZADEH FN, Aojula H, McHugh P, Allsop D, et al
    Effects of different isoforms of apoE on aggregation of the alpha-synuclein protein implicated in Parkinson's disease.
    Neurosci Lett. 2016 Feb 24. pii: S0304-3940(16)30108.
    PubMed     Text format     Abstract available


  135. FARIAS CC, Maes M, Bonifacio KL, Bortolasci CC, et al
    Highly specific changes in antioxidant levels and lipid peroxidation in Parkinson's disease and its progression: disease and staging biomarkers and new drug targets.
    Neurosci Lett. 2016 Feb 6. pii: S0304-3940(16)30078.
    PubMed     Text format     Abstract available


    January 2016
  136. GUO Z, Xu S, Du N, Liu J, et al
    Neuroprotective effects of stemazole in the MPTP-induced acute model of Parkinson's disease: involvement of the dopamine system.
    Neurosci Lett. 2016 Jan 28. pii: S0304-3940(16)30047.
    PubMed     Text format     Abstract available


  137. TOUCHETTE JC, Breckenridge JM, Wilken GH, Macarthur H, et al
    Direct intranigral injection of dopaminochrome causes degeneration of dopamine neurons.
    Neurosci Lett. 2016;612:178-84.
    PubMed     Text format     Abstract available


  138. POLNER B, Moustafa AA, Nagy H, Takats A, et al
    Dopamine improves exploration after expectancy violations and induces psychotic-like experiences in patients with Parkinson's disease.
    Neurosci Lett. 2016 Jan 25. pii: S0304-3940(16)30037.
    PubMed     Text format     Abstract available


  139. YALCINKAYA N, Haytural H, Bilgic B, Ozdemir O, et al
    Expression changes of genes associated with apoptosis and survival processes in Parkinson's disease.
    Neurosci Lett. 2016 Jan 21. pii: S0304-3940(16)30028.
    PubMed     Text format     Abstract available


  140. YUAN L, Song Z, Deng X, Xiong W, et al
    Association of the MTHFR rs1801131 and rs1801133 variants in sporadic Parkinson's disease patients.
    Neurosci Lett. 2016 Jan 21. pii: S0304-3940(16)30030.
    PubMed     Text format     Abstract available


  141. ALTMANN V, Schumacher-Schuh AF, Rieck M, Callegari-Jacques SM, et al
    Val66Met BDNF polymorphism is associated with Parkinson's disease cognitive impairment.
    Neurosci Lett. 2016 Jan 21. pii: S0304-3940(16)30029.
    PubMed     Text format     Abstract available


    December 2015
  142. ZHANG J, Yang B, Sun H, Zhou Y, et al
    Aquaporin-4 deficiency diminishes the differential degeneration of midbrain dopaminergic neurons in experimental Parkinson's disease.
    Neurosci Lett. 2015 Dec 31. pii: S0304-3940(15)30348.
    PubMed     Text format     Abstract available


  143. CHEN FX, Kang DZ, Chen FY, Liu Y, et al
    Grey Matter Atrophy Associated With Mild Cognitive Impairment in Parkinson's Disease.
    Neurosci Lett. 2015 Dec 29. pii: S0304-3940(15)30346.
    PubMed     Text format     Abstract available


  144. HARRISON IF, Anis HK, Dexter DT
    Associated Degeneration of Ventral Tegmental Area Dopaminergic Neurons in the Rat Nigrostriatal Lactacystin Model of Parkinsonism and their Neuroprotection by Valproate.
    Neurosci Lett. 2015 Dec 29. pii: S0304-3940(15)30343.
    PubMed     Text format     Abstract available


  145. XU J, Zhang J, Wang J, Li G, et al
    Abnormal fronto-striatal functional connectivity in Parkinson's disease.
    Neurosci Lett. 2015 Dec 24. pii: S0304-3940(15)30336.
    PubMed     Text format     Abstract available


  146. TAN T, Song Z, Yuan L, Xiong W, et al
    Genetic analysis of TREM2 variants in Chinese Han patients with sporadic Parkinson's disease.
    Neurosci Lett. 2015;612:189-192.
    PubMed     Text format     Abstract available


    November 2015
  147. HE S, Tan T, Song Z, Yuan L, et al
    Genetic analysis of MC1R variants in Chinese Han patients with sporadic Parkinson's disease.
    Neurosci Lett. 2015 Nov 25. pii: S0304-3940(15)30271.
    PubMed     Text format     Abstract available


  148. TOROK R, Zadori D, Torok N, Csility E, et al
    An assessment of the frequency of mutations in the GBA and VPS35 genes in Hungarian patients with sporadic Parkinson's disease.
    Neurosci Lett. 2015 Nov 4. pii: S0304-3940(15)30238.
    PubMed     Text format     Abstract available


    October 2015
  149. NAKASO K, Horikoshi Y, Takahashi T, Hanaki T, et al
    Estrogen receptor-mediated effect of delta-tocotrienol prevents neurotoxicity and motor deficit in the MPTP mouse model of Parkinson's disease.
    Neurosci Lett. 2015 Oct 30. pii: S0304-3940(15)30225.
    PubMed     Text format     Abstract available


  150. SCHIENLE A, Ille R, Wabnegger A
    Experience of negative emotions in Parkinson's disease: an fMRI investigation.
    Neurosci Lett. 2015 Oct 21. pii: S0304-3940(15)30209.
    PubMed     Text format     Abstract available


  151. KALINDERI K, Bostantjopoulou S, Katsarou Z, Dimikiotou M, et al
    D620N mutation in the VPS35 gene and R1205H mutation in the EIF4G1 gene are uncommon in the Greek population.
    Neurosci Lett. 2015;606:113-6.
    PubMed     Text format     Abstract available


  152. CARVALHO DZ, Schonwald SV, Schumacher-Schuh AF, Braga CW, et al
    Overnight S100B in Parkinson's Disease: A glimpse into sleep-related neuroinflammation.
    Neurosci Lett. 2015 Oct 7. pii: S0304-3940(15)30173.
    PubMed     Text format     Abstract available


    September 2015
  153. ARIZA D, Lopes FN, Crestani CC, Martins-Pinge MC, et al
    CHEMOREFLEX AND BAROREFLEX ALTERATIONS IN PARKINSONISM INDUCED BY 6-OHDA IN UNANESTHETIZED RATS.
    Neurosci Lett. 2015 Sep 23. pii: S0304-3940(15)30150.
    PubMed     Text format     Abstract available


    August 2015
  154. GU C, Shen T, An H, Yuan C, et al
    Combined therapy of Di-Huang-Yi-Zhi with Donepezil in patients with Parkinson's disease dementia.
    Neurosci Lett. 2015 Aug 18. pii: S0304-3940(15)30089.
    PubMed     Text format     Abstract available


  155. ALDECOA I, Navarro-Otano J, Stefanova N, Sprenger FS, et al
    Alpha-synuclein immunoreactivity patterns in the enteric nervous system.
    Neurosci Lett. 2015;602:145-9.
    PubMed     Text format     Abstract available


  156. HALDER T, Raj J, Sharma V, Das P, et al
    Novel P-TEN-induced putative kinase 1 (PINK1) variant in Indian Parkinson's disease Patient.
    Neurosci Lett. 2015 Aug 14. pii: S0304-3940(15)30091.
    PubMed     Text format     Abstract available


  157. GUO JF, Dong XL, Xu Q, Li N, et al
    Exon dosage analysis of parkin gene in Chinese sporadic Parkinson's disease.
    Neurosci Lett. 2015 Aug 1. pii: S0304-3940(15)30066.
    PubMed     Text format     Abstract available


    July 2015
  158. ZHANG X, Niu M, Li H, Xie A, et al
    RIT2 rs12456492 polymorphism and the risk of Parkinson's disease: A meta-analysis.
    Neurosci Lett. 2015 Jul 15. pii: S0304-3940(15)30024.
    PubMed     Text format     Abstract available


  159. BRENNER S, Wersinger C, Gasser T
    Transcriptional regulation of the alpha-synuclein gene in human brain tissue.
    Neurosci Lett. 2015;599:140-5.
    PubMed     Text format     Abstract available


    June 2015
  160. PAN X, Chen C, Huang J, Wei H, et al
    Neuroprotective effect of combined therapy with hyperbaric oxygen and madopar on 6-hydroxydopamine-induced Parkinson's disease in rats.
    Neurosci Lett. 2015 Jun 20. pii: S0304-3940(15)00473.
    PubMed     Text format     Abstract available


  161. WEN P, Li M, Xiao H, Ding R, et al
    Low-frequency stimulation of the pedunculopontine nucleus affects gait and the neurotransmitter level in the ventrolateral thalamic nucleus in 6-OHDA Parkinsonian rats.
    Neurosci Lett. 2015 Jun 5. pii: S0304-3940(15)00435.
    PubMed     Text format     Abstract available


    May 2015
  162. CIURLEO R, Bonanno L, Lorenzo GD, Bramanti P, et al
    Metabolic changes in de novo Parkinson's disease after dopaminergic therapy: A proton magnetic resonance spectroscopy study.
    Neurosci Lett. 2015 May 22. pii: S0304-3940(15)00409.
    PubMed     Text format     Abstract available


  163. WANG X, Yu S, Li F, Feng T, et al
    Detection of alpha-synuclein oligomers in red blood cells as a potential biomarker of Parkinson's disease.
    Neurosci Lett. 2015 May 18. pii: S0304-3940(15)00387.
    PubMed     Text format     Abstract available


  164. WANG S, Xu YF, Ding XY, Liu ZR, et al
    Association between bone marrow stromal cell antigen 1 gene polymorphisms and the susceptibility to Parkinson's disease: a meta-analysis.
    Neurosci Lett. 2015 May 15. pii: S0304-3940(15)00383.
    PubMed     Text format     Abstract available


  165. PREMA A, Janakiraman U, Manivasagam T, Thenmozhi AJ, et al
    Neuroprotective effect of lycopene against MPTP induced experimental Parkinson's disease in mice.
    Neurosci Lett. 2015 May 14. pii: S0304-3940(15)00381.
    PubMed     Text format     Abstract available


    February 2015
  166. ASANO T, Koike M, Sakata S, Takeda Y, et al
    Possible involvement of iron-induced oxidative insults in neurodegeneration.
    Neurosci Lett. 2015;588:29-35.
    PubMed     Text format     Abstract available


    January 2015
  167. WIEMERSLAGE L, Lee D
    Role of Drosophila calcium channel cacophony in dopaminergic neurodegeneration and neuroprotection.
    Neurosci Lett. 2015;584:342-6.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: